Gapping down
In reaction to disappointing earnings/guidance:
- TLRD -26.3%, LLNW -23.7%, OXM -12.7%
Other news:
- AGTC -39.8% (Applied Genetic Technologies (halted) announces topline interim six-month data from Phase 1/2 X-Linked Retinoschisis clinical study did not demonstrate signs of clinical activity; termination of Biogen (BIIB) collaboration)
- VBIV -13.3% (proposed public offering of common shares; size not disclosed)
- TOCA -5.6% (prices offering of 3 mln shares of common stock at $10.00 per share)
- MRNS -5.5% (prices offering of 12 mln shares of common stock at $3.75 per share)
- HASI -3.9% (prices 5 mln shares of common stock), DB -1% (after making notable move higher on reports that Germany's government is discussing potential plans to facilitate a merger between co and Commerzbank)
Analyst comments:
- NBR -3.5% (downgraded to Mkt Perform at Raymond James)
- FIVN -2.5% (downgraded to Neutral from Overweight at JP Morgan)
- INTU -2% (downgraded to Underweight from Neutral at JP Morgan)
- MDSO -1.9% (downgraded to Underweight from Neutral at JP Morgan)
- ADSK -1.2% (downgraded to Neutral from Overweight at JP Morgan)
